Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.84
0.00 (0.13%)
At close: Sep 05, 2025, 3:59 PM
0.82
-2.94%
After-hours: Sep 05, 2025, 06:29 PM EDT
Biofrontera Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Government and Payor Rebates Revenue | 167K | 90K | 82K | 79K | 231K | 51K | 49K | 95K | 45K |
| Government and Payor Rebates Revenue Growth | +85.56% | +9.76% | +3.80% | -65.80% | +352.94% | +4.08% | -48.42% | +111.11% | n/a |
| Returns Revenue | 78K | 77K | 6K | n/a | 6K | n/a | n/a | 39K | 38K |
| Returns Revenue Growth | +1.30% | +1183.33% | n/a | -100.00% | n/a | n/a | n/a | +2.63% | n/a |
| Prompt Pay Discounts Revenue | 6K | 6K | 52K | n/a | 52K | n/a | n/a | 43K | n/a |
| Prompt Pay Discounts Revenue Growth | 0.00% | -88.46% | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.53M | 8.65M | 8.17M | 8.43M | 7.95M | 9.25M | 9.06M | 8.62M | 11.55M | 9.83M | 10.21M | 7.94M | 10.02M | 7.71M | 9.28M | 17.25M | 5.75M | 4.92M | 4.16M | 4.3M | 3.67M | 5.98M |
| Selling, General, and Administrative Revenue Growth | +21.67% | +5.90% | -3.01% | +6.01% | -14.09% | +2.10% | +5.12% | -25.36% | +17.51% | -3.73% | +28.63% | -20.76% | +29.88% | -16.88% | -46.22% | +200.10% | +16.78% | +18.23% | -3.23% | +17.25% | -38.68% | n/a |
| Research and Development Revenue | 870K | 1.21M | 782K | 669K | 621K | 17K | 33K | 33K | 11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -27.92% | +54.35% | +16.89% | +7.73% | +3552.94% | -48.48% | 0.00% | +200.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |